Previous 10 | Next 10 |
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will...
Repro Med Systems (NASDAQ:KRMD) has added ~6.5% in the post-market after announcing the FDA 510(k) clearance for FREEDOM60 Infusion System that would expand its on-label use. Therefore, FREEDOM60 is now authorized for use in two additional subcutaneous immunoglobulin (SCIg...
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced FDA 510(k) clearance ...
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced it will host an investor day to provide an update...
Fossil Group (NASDAQ:FOSL) +32% on Q3 earnings. Babylon (NYSE:BBLN) +28%. Affirm Holdings (NASDAQ:AFRM) +27% on FQ1 earnings. Opendoor Technologies (NASDAQ:OPEN) +18% on Q3 earnings. Society Pass (NASDAQ:SOPA) +19%. ReWalk Robotics (NASDAQ:RWLK) +16% on Q3 earnings. Lordstown Motors...
Repro Med Systems, Inc. (KRMD) Q3 2021 Earnings Conference Call November 10, 2021, 04:30 PM ET Company Participants Greg Chodaczek - IR Linda Tharby - President and CEO Karen Fisher - CFO Conference Call Participants Trenton McCarthy - Craig-Hallum Capital Group Presentation Operator Good day...
Repro Med Systems (NASDAQ:KRMD) dba KORU Medical Systems has received a 510k clearance for use of the company's FreedomEdge infusion pump to deliver Hizentra [immune globulin subcutaneous (human) 20% liquid] 20 mL prefilled syringes. KORU Medical shares surge more than 19% post...
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of...
KORU Medical’s Freedom Edge becomes the only device specifically cleared for delivery of subcutaneous Ig prefilled syringes Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology comp...
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced its participation in ...
News, Short Squeeze, Breakout and More Instantly...
KORU Medical Systems Inc. Company Name:
KRMD Stock Symbol:
NYSE Market:
KORU Medical Systems Inc. Website:
2024-07-02 12:15:04 ET Canaccord Genuity analyst issues BUY recommendation for KRMD on July 2, 2024 10:05AM ET. The previous analyst recommendation was Buy. KRMD was trading at $2.25 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
2024-07-02 12:00:07 ET Kyle Rose from Canaccord Genuity issued a price target of $3.00 for KRMD on 2024-07-02 10:05:00. The adjusted price target was set to $3.00. At the time of the announcement, KRMD was trading at $2.25. The overall price target consensus is at $4.50 ...
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announ...